IP Library › Granted Patent US 11,898,160
Granted Patent B2
US 11,898,160 · App. 12/577,103 · Granted Feb 13, 2024

Method for maintaining pluripotency in cells

Inventors: Cynthia C. Bamdad (Waltham, MA); Shawn P. Fessler (Arlington, MA)
Assignee: MINERVA BIOTECHNOLOGIES CORPORATION
C12N5/0606C12N5/0696C12N2501/40C12N2501/50C12N2501/602C12N2501/603C12N2501/604C12N2501/998
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,898,160
App. No.
12/577,103
Granted
Feb 13, 2024
Kind
B2
Abstract

The present application describes a method for inducing or maintaining pluripotency in a cell by contacting the cell with a biological or chemical species that increases MUC1* activity.

Claims (22)

1. A method for maintaining cell pluripotency or cell stemness, the method comprising:

contacting a cell characterized by an expression of OCT4 with an effective amount of an exogenous nucleoside diphosphate protein kinase 7 (NME7),

thereby maintaining the expression of the OCT4 in the cell.

2. The method of claim 1 , wherein the NME7 is a polypeptide.

3. The method of claim 1 , wherein the cell is a stem cell.

4. The method of claim 1 , wherein the cell is an undifferentiated embryonic stem cell (ESC) or a pluripotent stem cell.

5. The method of claim 1 , wherein the cell is a human cell.

6. The method of claim 1 , wherein said contacting comprises contacting a plurality of cells that comprises the cell.

7. The method of claim 1 , wherein said contacting occurs in vitro.

8. The method of claim 1 , wherein said contacting occurs in the absence of one or more feeder cells or an extract thereof.

9. The method of claim 1 , wherein said contacting occurs in the absence of a basic fibroblast growth factor (bFGF).

10. The method of claim 1 , wherein the method stimulates or enhances the growth of the cell.

11. A method for inducing pluripotency in a cell, the method comprising:

contacting the cell with transcription factors Oct4, Sox2, and Nanog, and

contacting the cell with an exogenous nucleoside diphosphate protein kinase 7 (NME7).

12. The method of claim 11 , wherein the NME7 is a polypeptide.

13. The method of claim 11 , wherein the cell is a fibroblast.

14. The method of claim 11 , wherein the cell is a human cell.

15. The method of claim 11 , wherein the method produces an induced pluripotent cell.

16. The method of claim 11 , wherein said contacting occurs in vitro.

17. The method of claim 11 , further comprising contacting the cell with one or more transcription factors selected from Klf4, c-Myc, and Lin28.

18. The method of claim 11 , wherein contacting the cell with transcription factors comprises introducing nucleic acids encoding said transcription factors into the cell.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2009
From: BAMDAD, CYNTHIA C., DR.; FESSLER, SHAWN P., DR.
To: MINERVA BIOTECHNOLOGIES CORPORATION
Reel/Frame 023354/0778 →
Continuity (2)
Provisional Application 61104231 · Oct 9, 2008
Related Publication 20100093092A1 · Apr 15, 2010
Cited By (3)
US 12,195,728 US 12,415,868 US 12,491,259